These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35391578)

  • 21. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.
    Hu F; Zhu D; Wang F; Morrissey I; Wang J; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i33-43. PubMed ID: 27048581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin.
    Petrina MAB; Cosentino LA; Rabe LK; Hillier SL
    Anaerobe; 2017 Oct; 47():115-119. PubMed ID: 28522362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Tunger A; Sancak B; Bıçakçıgil A; Altun B; Aktas Z; Kayacan C; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i88-i99. PubMed ID: 32337598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
    Soyletir G; Altinkanat G; Gur D; Altun B; Tunger A; Aydemir S; Kayacan C; Aktas Z; Gunaydin M; Karadag A; Gorur H; Morrissey I; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i71-83. PubMed ID: 27048584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Anwar S; Nizamuddin S; Malik N; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i76-i87. PubMed ID: 32337594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    Torumkuney D; Bratus E; Yuvko O; Pertseva T; Morrissey I
    J Antimicrob Chemother; 2020 Apr; 75(Suppl 1):i100-i111. PubMed ID: 32337596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
    Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
    Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibility of Propionibacterium acnes isolated from orthopaedic implant-associated infections.
    Khassebaf J; Hellmark B; Davidsson S; Unemo M; Nilsdotter-Augustinsson Å; Söderquist B
    Anaerobe; 2015 Apr; 32():57-62. PubMed ID: 25541476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of E. coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelines.
    Vanstokstraeten R; Belasri N; Demuyser T; Crombé F; Barbé K; Piérard D
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2371-2377. PubMed ID: 34175999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study.
    Bielicki I; Schmid H; Atkinson A; Kahlert CR; Berger C; Troillet N; Marschall J; Bielicki JA;
    Antimicrob Resist Infect Control; 2023 Sep; 12(1):106. PubMed ID: 37749585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
    Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
    Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic bacteria characteristics and drug resistance in acute, delayed, and chronic periprosthetic joint infection: A retrospective analysis of 202 patients.
    Chang Y; Li Y; Fan T; Jiang K; Lv J; Huang J
    Int Wound J; 2023 Oct; 20(8):3315-3323. PubMed ID: 37186450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    Torumkuney D; Mayanskiy N; Edelstein M; Sidorenko S; Kozhevin R; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v14-v21. PubMed ID: 29659881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions.
    Pinheiro ET; Gomes BP; Drucker DB; Zaia AA; Ferraz CC; Souza-Filho FJ
    Int Endod J; 2004 Nov; 37(11):756-63. PubMed ID: 15479258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
    Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
    Dahlen G; Preus HR
    Anaerobe; 2017 Feb; 43():94-98. PubMed ID: 27988390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.